Adjuvant effect of physical exercise on immune response to COVID-19 vaccination and interactions with stress

体育锻炼对 COVID-19 疫苗接种免疫反应的辅助作用以及与压力的相互作用

基本信息

  • 批准号:
    10593597
  • 负责人:
  • 金额:
    $ 22.49万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-06 至 2025-08-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY / ABSTRACT Vaccination is an effective public health measure, yet host factors including advanced age, sex, obesity, physical or mental health status may influence vaccine efficacy. Adjuvants improve immunogenicity to vaccination but often result in greater side effects. As an alternative to the inclusion of adjuvants in the vaccine formulation, evidence suggests physical exercise performed at the time of immunization may serve as an effective non-pharmacological approach with the potential for greater impact in individuals with suboptimal immune response and reduced reactogenicity. The effect of host factors on immune response to SARS-CoV-2 and long-term protection remains to be established, and positive findings for an adjuvant-like effect of physical exercise would have an immediate translational impact. However, major barriers to the implementation of exercise are inconsistent findings and a gap in the knowledge of the mechanisms that underlie such effects. Our recent publication shows that we have identified an exercise protocol that consistently increases antibody response to vaccines that is reproducible across several different vaccines. This finding holds the potential to transform vaccine efficacy and address questions on the breadth and durability of immune response and underlying mechanisms. The goals of this application are to determine the extent to which physical exercise exhibits an adjuvant-like effect across long-term antibody and T cell-mediated immune responses to COVID-19 mRNA-based vaccines and establish the degree of immune enhancement in individuals who may have suboptimal vaccine response due to high psychological stress. An additional goal is to identify potential operative mechanisms, and compelling preliminary data show promise for metabolism-related mechanisms, a new direction in this field of study. Aim 1 will identify the extent to which a single exercise session applied at the time of initial immunization shapes the magnitude, breadth, and durability of immune response to SARS-CoV-2 mRNA vaccine. Outcome measures are serum anti-spike receptor-binding domain (RBD) IgG titer, neutralizing antibody, antigen-specific CD4+ and CD8+ T cell response measured up to one-year post-immunization. Aim 2 will determine the influence of psychological stress on antibody and antigen-specific CD4+ and CD8+ T cell immune response to SARS-CoV-2 immunization and the extent to which exercise may override any potential effect of stress. Aim 3 will apply transcriptomic (RNA-Seq) and metabolomic (Raman) measures to identify pathways by which exercise influences immune response to vaccination. The long-term goals of this research direction are to refine and develop behavioral interventions that optimize immunity and more broadly apply the findings learned with respect to critical pathways of immunogenicity to optimize vaccine development for currently underserved populations.
项目总结/摘要 接种疫苗是一种有效的公共卫生措施,但宿主因素包括高龄、性别、肥胖, 身体或心理健康状况可能影响疫苗的效力。佐剂改善免疫原性, 接种疫苗,但往往会产生更大的副作用。作为疫苗中包含佐剂的替代品 有证据表明,在免疫接种时进行的体育锻炼可能是一种预防免疫接种的方法。 有效的非药理学方法,可能对次优个体产生更大影响 免疫应答和降低的反应原性。宿主因素对SARS-CoV-2免疫应答的影响 和长期的保护仍有待建立,和积极的发现,一个类似的影响,物理 运动会产生直接的转化效果。然而,执行《公约》的主要障碍是: 然而,在对这些影响的机制的认识方面存在着不一致的结论和空白。我们 最近的出版物表明,我们已经确定了一种运动方案, 对疫苗的反应在几种不同的疫苗中是可重复的。这一发现有可能 改变疫苗效力,解决免疫反应的广度和持久性问题, 基本机制。这个应用程序的目标是确定体育锻炼的程度 在对COVID-19的长期抗体和T细胞介导的免疫应答中表现出类似于解毒剂的作用 基于mRNA的疫苗,并确定可能有免疫缺陷的个体的免疫增强程度。 由于心理压力大,疫苗反应不佳。另一个目标是确定潜在的操作 机制,令人信服的初步数据显示,代谢相关机制的承诺,一个新的 在这个研究领域的方向。目标1将确定当时一次练习的应用程度 初始免疫的大小决定了对SARS-CoV-2 mRNA的免疫应答的大小、广度和持久性 疫苗结果指标为血清抗棘突受体结合域(RBD)IgG滴度,中和 抗体、抗原特异性CD 4+和CD 8 + T细胞应答在免疫后一年内测量。目的2 将确定心理应激对抗体和抗原特异性CD 4+和CD 8 + T细胞的影响 对SARS-CoV-2免疫的免疫反应以及运动可能压倒任何潜在影响的程度 压力的影响。目标3将应用转录组学(RNA-Seq)和代谢组学(拉曼)方法来鉴定 运动影响对疫苗接种的免疫反应的途径。这项研究的长期目标是 方向是完善和开发优化免疫力的行为干预措施,并更广泛地应用 关于免疫原性关键途径的研究结果,以优化疫苗开发, 目前服务不足的人群。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Marian L Kohut其他文献

Marian L Kohut的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Marian L Kohut', 18)}}的其他基金

Combination nanovaccine-based immunization against influenza virus in the aged: immunity and protection
基于纳米疫苗的老年人流感病毒联合免疫:免疫与保护
  • 批准号:
    10211470
  • 财政年份:
    2021
  • 资助金额:
    $ 22.49万
  • 项目类别:
Combination nanovaccine-based immunization against influenza virus in the aged: immunity and protection
基于纳米疫苗的老年人流感病毒联合免疫:免疫与保护
  • 批准号:
    10353425
  • 财政年份:
    2021
  • 资助金额:
    $ 22.49万
  • 项目类别:
Combination nanovaccine-based immunization against influenza virus in the aged: immunity and protection
基于纳米疫苗的老年人流感病毒联合免疫:免疫与保护
  • 批准号:
    10553681
  • 财政年份:
    2021
  • 资助金额:
    $ 22.49万
  • 项目类别:
Exercise-induced immunomodulation in the aged: Mechanisms
老年人运动引起的免疫调节:机制
  • 批准号:
    8039182
  • 财政年份:
    2007
  • 资助金额:
    $ 22.49万
  • 项目类别:
Exercise-induced immunomodulation in the aged
老年人运动诱导的免疫调节
  • 批准号:
    7614466
  • 财政年份:
    2007
  • 资助金额:
    $ 22.49万
  • 项目类别:
Exercise-induced immunomodulation in the aged
老年人运动诱导的免疫调节
  • 批准号:
    7408516
  • 财政年份:
    2007
  • 资助金额:
    $ 22.49万
  • 项目类别:
Exercise-induced immunomodulation in the aged: Mechanisms
老年人运动引起的免疫调节:机制
  • 批准号:
    7778304
  • 财政年份:
    2007
  • 资助金额:
    $ 22.49万
  • 项目类别:
Exercise-induced immunomodulation in the aged
老年人运动诱导的免疫调节
  • 批准号:
    7196047
  • 财政年份:
    2007
  • 资助金额:
    $ 22.49万
  • 项目类别:
Exercise & influenza immunity:Psychoneuroendocrine Model
锻炼
  • 批准号:
    6779867
  • 财政年份:
    2002
  • 资助金额:
    $ 22.49万
  • 项目类别:
Exercise & influenza immunity:Psychoneuroendocrine Model
锻炼
  • 批准号:
    6471076
  • 财政年份:
    2002
  • 资助金额:
    $ 22.49万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.49万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 22.49万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.49万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.49万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.49万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.49万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.49万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 22.49万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 22.49万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 22.49万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了